Most cited papers from Maastro Clinic

Maastro Clinic

What are the most cited papers from Maastro Clinic?

The most cited paper from Maastro Clinic is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "Radiomics: Extracting more information from medical images using advanced feature analysis" (6,202) and "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (6,023).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 314 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors	23 Nov 2018	11,535
2	Radiomics: Extracting more information from medical images using advanced feature analysis Philippe Lambin, Emmanuel Rios-Velazquez, Ralph T. H. Leijenaar et al. · European Journal of Cancer Open access	16 Jan 2012	6,202
3	Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors	2 Jan 2016	6,023
4	Radiomics: the bridge between medical imaging and personalized medicine Philippe Lambin, Ralph T. H. Leijenaar, Timo M. Deist et al. · Nature Reviews Clinical Oncology ReviewOpen access	4 Oct 2017	5,839
5	Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach Hugo J.W.L. Aerts, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar et al. · Nature Communications Open access	3 Jun 2014	5,287
6	Radiomics: the process and the challenges Virendra Kumar, Yuhua Gu, Satrajit Basu et al. · Magnetic Resonance Imaging Open access	13 Aug 2012	2,294
7	Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer Jakob Nikolas Kather, Alexander T. Pearson, Niels Halama et al. · Nature Medicine Open access	3 Jun 2019	1,500
8	Small-cell lung cancer Jan P. van Meerbeeck, Dean Anthony Fennell, Dirk KM De Ruysscher · The Lancet	12 May 2011	1,252
9	Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer Monique Maas, Geerard L. Beets, Doenja M. J. Lambregts et al. · Journal of Clinical Oncology	8 Nov 2011	1,164
10	Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Remi A. Nout, VTHBM Smit, Hein Putter et al. · The Lancet	Mar 2010	1,154
11	Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial Eva Versteijne et al. · Journal of Clinical Oncology Open access	27 Feb 2020	1,101
12	Machine Learning methods for Quantitative Radiomic Biomarkers Chintan Parmar, Patrick Großmann, Johan Bussink et al. · Scientific Reports Open access	17 Aug 2015	1,040
13	CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19—Definition and Evaluation Mathias Prokop, Wouter M. van Everdingen, Tjalco van Rees Vellinga et al. · Radiology Open access	27 Apr 2020	964
14	Repeatability and Reproducibility of Radiomic Features: A Systematic Review Alberto Traverso, Leonard Wee, Andre L.A.J. Dekker et al. · International Journal of Radiation OncologyBiologyPhysics ReviewOpen access	5 Jun 2018	920
15	The genetic architecture of the human cerebral cortex Katrina L. Grasby et al. · Science Open access362 authors	19 Mar 2020	910
16	Radiotherapy toxicity Dirk De Ruysscher, Gabriele Niedermann, N.G. Burnet et al. · Nature Reviews Disease Primers Review	21 Feb 2019	882
17	Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse et al. · Clinical Cancer Research	22 Mar 2016	872
18	The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 Kasper M. A. Rouschop, Twan van den Beucken, Ludwig Jerome Dubois et al. · Journal of Clinical Investigation Open access	28 Dec 2009	821
19	Analysis of DNA methylation in cancer: location revisited Alexander Koch, Sophie C. Joosten, Zheng Feng et al. · Nature Reviews Clinical Oncology Review	17 Apr 2018	777
20	Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial Eva Versteijne et al. · Journal of Clinical Oncology Open access	27 Jan 2022	755
21	Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders Siddharth Srivastava, Jamie A. Love-Nichols, Kira A. Dies et al. · Genetics in Medicine Open access	10 Jun 2019	744
22	ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer Birgitte Vrou Offersen, Liesbeth Jorinne Boersma, Carine Kirkove et al. · Radiotherapy and Oncology Open access	2015	740
23	SpekCalc: a program to calculate photon spectra from tungsten anode x-ray tubes Gavin G. Poludniowski, Guillaume Landry, F DeBlois et al. · Physics in Medicine and Biology	Sep 2009	729
24	CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma Thibaud P. Coroller, Patrick Großmann, Ying Hou et al. · Radiotherapy and Oncology Open access	Mar 2015	719
25	Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Harry G M M Bartelink et al. · The Lancet Oncology Open access	8 Dec 2014	696
26	Pan-cancer image-based detection of clinically actionable genetic alterations Jakob Nikolas Kather et al. · Nature Cancer Open access	27 Jul 2020	688
27	LC3/GABARAP family proteins: autophagy‐(un)related functions Marco B.E. Schaaf, Tom G. Keulers, Marc Vooijs et al. · The FASEB Journal	6 Sep 2016	678
28	Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas Martin J. van den Bent, JS Wefel, David Schiff et al. · The Lancet Oncology	7 Apr 2011	655
29	Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie M. de Boer et al. · The Lancet Oncology Open access	12 Feb 2018	640
30	Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Anne‐Marie C. Dingemans, Martin Früh, Andrea Ardizzoni et al. · Annals of Oncology Open access	20 Apr 2021	620
31	Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation Chintan Parmar, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar et al. · PLoS ONE Open access	15 Jul 2014	618
32	Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers Stefano Trebeschi, Silvia Girolama Drago, Nicolai J. Birkbak et al. · Annals of Oncology Open access	19 Mar 2019	574
33	Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach Johannes Albertus Langendijk, Philippe Lambin, Dirk De Ruysscher et al. · Radiotherapy and Oncology Open access	Jun 2013	556
34	Transparency of deep neural networks for medical image analysis: A review of interpretability methods Zohaib Salahuddin, Henry C. Woodruff, Avishek Chatterjee et al. · Computers in Biology and Medicine Open access	4 Dec 2021	510
35	Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force Riccardo Soffietti, Brigitta G. Baumert, Lorenzo Bello et al. · European Journal of Neurology Open access	16 Aug 2010	506
36	Novel, improved grading system(s) for IDH-mutant astrocytic gliomas Mitsuaki Shirahata et al. · Acta Neuropathologica Open access	23 Apr 2018	479
37	A literature review of electronic portal imaging for radiotherapy dosimetry Wouter van Elmpt, Leah N. McDermott, Sebastiaan M. J. J. G. Nijsten et al. · Radiotherapy and Oncology	15 Aug 2008	478
38	Hypoxia, Hypoxia-Inducible Transcription Factor, and Macrophages in Human Atherosclerotic Plaques Are Correlated With Intraplaque Angiogenesis Judith C. Sluimer, Jean‐Marie Gasc, J.L. van Wanroij et al. · Journal of the American College of Cardiology Open access	25 Mar 2008	469
39	Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials Tjalling Bosse, Elke E.M. Peters, Carien L. Creutzberg et al. · European Journal of Cancer Open access	6 Jun 2015	453
40	Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer Chintan Parmar, Ralph T. H. Leijenaar, Patrick Großmann et al. · Scientific Reports Open access	5 Jun 2015	442
41	Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer Milou H. Martens, Monique Maas, Luc A. Heijnen et al. · JNCI Journal of the National Cancer Institute Open access	10 Aug 2016	431
42	Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability Ralph T. H. Leijenaar, Sara Carvalho, Emmanuel Rios Velazquez et al. · Acta Oncologica Open access	9 Sep 2013	431
43	The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis Ralph T. H. Leijenaar, Georgi I. Nalbantov, Sara Carvalho et al. · Scientific Reports Open access	5 Aug 2015	426
44	Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer Chintan Parmar, Patrick Großmann, Derek H. F. Rietveld et al. · Frontiers in Oncology Open access	3 Dec 2015	418
45	The role of radiotherapy in the treatment of malignant salivary gland tumors Chris H.J. Terhaard, Herman Lubsen, Coen R. N. Rasch et al. · International Journal of Radiation OncologyBiologyPhysics	30 Dec 2004	412
46	Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study Martin J. van den Bent et al. · The Lancet Open access	8 Aug 2017	403
47	Predicting outcomes in radiation oncology—multifactorial decision support systems Philippe Lambin, Ruud G.P.M. van Stiphout, Maud H. W. Starmans et al. · Nature Reviews Clinical Oncology ReviewOpen access	20 Nov 2012	402
48	Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma Carien L. Creutzberg, Remi A. Nout, Marnix L.M. Lybeert et al. · International Journal of Radiation OncologyBiologyPhysics Open access	8 Jun 2011	380
49	Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer Tim Lustberg, Johan van Soest, Mark J. Gooding et al. · Radiotherapy and Oncology Open access	5 Dec 2017	372
50	Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control Marianne Koritzinsky, Michaël G. Magagnin, Twan van den Beucken et al. · The EMBO Journal Open access	9 Feb 2006	369

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.